RT @khalideljaaly: Our 2017 meta-analysis of RCTs https://t.co/pffqeMT5CB found higher clinical failure in regimens lacking this activity b…
Our 2017 meta-analysis of RCTs https://t.co/pffqeMT5CB found higher clinical failure in regimens lacking this activity but we included any CAP patients regardless of isolated organisms. So, it was not clear if the benefit was due to activity against atypic
@TomWalshMD13 @JustinJWChoi @ABsteward @BradSpellberg Our meta-analysis of RCTs found a significant benefit in clinical cure with empiric atypical regimens, but it did not achieve statistical significance with mortality. Debatable topic 🤷🏽♂️ https://t.co/
@alishehri1400 @Ahmad_Odadi @ABsteward @accpinfdprn @ESCMID @WesKufel @blandman19 @ASPphysician @TimbrookTT @IDstewardship @IDSAInfo @accpchest @DrToddLee @khalid_eljaaly2 Thanks for tagging. Our meta: https://t.co/pffqeMT5CB It was not discussed. However,